WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹173 Cr | ₹109 Cr | ₹64 Cr | ₹67 Cr | ₹160 Cr |
What is the latest Total Debt ratio of WANBURY ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹173 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹67 Cr |
| Mar2021 | ₹160 Cr |
How is Total Debt of WANBURY Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹173 Cr | 58.53 | |
| Mar2024 | ₹109 Cr | 70.37 | |
| Mar2023 | ₹64 Cr | -4.30 | |
| Mar2022 | ₹67 Cr | -58.22 | |
| Mar2021 | ₹160 Cr | - | |
Compare Total Debt of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹848.1 Cr | -4.4% | 12.4% | 33.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -4.4% |
12.4% |
33.4% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses